Abstract. This research work describes the synthesis and biological properties of some novel polysubstituted fused heterocyclic ring systems namely; pyrano [4,3-c] pyrazoles and pyrazolo [4,3-c]pyridines. Such targeted compounds where designed so as to hybridize the pyrazole ring with the pyrone and/or pyridine moieties, respectively, hoping to obtain synergistic anticancer and/or antimicrobial activities. The chemistry of the reactions employed in the synthesis of the target compounds together with their chemical behaviour, are discussed and the structures of the newly synthesized compounds were confirmed by the IR and 1 H-NMR spectral data. All the synthesized compounds showed weak anticancer activity according to the protocol of the National Cancer Institute (NCI), Maryland, USA. Additionally, they showed weak antimicrobial activity against some bacteria and fungi.
Introduction
Among the wide variety of heterocycles that have been explored for developing potential pharmacologically active compounds, pyrazoles fused with different heterocycles that are known to contribute to various chemotherapeutic effects have emerged as antimicrobial, [1, 2] antifungal, [3] and antiviral agents. [4] In addition, some fused pyrazole derivatives were reported to induce various antileukemic, [5] antitumor [6, 7] and antiproliferative [8, 9] activities. On the other hand, investigations in the chemistry and biology of 2-pyrones have become highly intensified with the recognition that they constitute an essential pharmacophore in many naturally occurring and biologically active agents. [10] Some pyrones were reported to possess distinctive chemotherapeutic potentials including cytotoxicity against some human cancer cell lines. [11, 12] Furthermore, a wide range of chemotherapeutic activities have been ascribed to pyridine derivatives including antimicrobial, [13, 14] and anticancer activities. [15] [16] [17] Motivated by these facts, we were interested to synthesize and investigate the in vitro anticancer, antibacterial and antifungal activities of some novel polysubstituted fused heterocyclic ring systems namely; pyrano [4,3-c] pyrazoles and pyrazolo [4,3-c] pyridines. Such targeted compounds where designed so as to hybridize the pyrazole ring with the pyrone and/or pyridine moieties, respectively, hoping to obtain synergistic anticancer and/or antimicrobial activities. The structures of the newly synthesized compounds were confirmed with elementary microanalyses and substantiated with IR and 1 H-NMR data. The target compounds have been subjected to the National Cancer Institute NCI in vitro disease-oriented human cells screening panel assay, Maryland, USA, to screen their anticancer activity. In addition, the in vitro antibacterial and antifungal activities of the target compounds were also tested.
Experimental
Melting points were determined in open glass capillaries on a Gallenkamp melting point apparatus and were uncorrected. The infrared (IR) spectra were recorded on Shimadzu FT-IR 8400S infrared spectrophotometer using the KBr plate technique. The 1 H-NMR and 13 C-NMR spectra were recorded on a Varian EM 360 spectrometer using tetramethylsilane as the internal standard and DMSO-d 6 as the solvent (Chemical shifts in δ, ppm). Splitting patterns were designated as follows: S: Singlet; D: Doublet; M: Multiplet. Elemental analyses were performed at the Microanalytical Unit, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia, and the found values were within ±0.4% of the theoretical values. Follow up of the reactions and checking the homogeneity of the compounds were made by TLC on silica gel-protected aluminum sheets (Type 60 F254, Merck) and the spots were detected by exposure to UV-lamp at λ 254 nm.
A solution of dehydroacetic acid (1.68 g, 0.01 mol) in ethanol (20 mL) was refluxed with hydrazine hydrate (1.1 mL, 0.022 mol) for 2 h. The reaction mixture was concentrated to half its volume and allowed to cool. The solid product separated was filtered, washed with cold ethanol and recrystallized from ethanol. Physicochemical and analytical data are recorded in Table 1 . H-NMR and IR spectra are shown in Table 2 .
13 C-NMR spectrum is recorded in Table 3 . Table 3 . 13 C-NMR (δ-ppm) spectra of some 2-11 derivatives. A mixture of the pyrazolopyridine 2 (0.3g, 0.002 mol) and the appropriate aldehyde (0.002 mol) in benzene (10 mL) was heated on a boiling water bath for 4-6 h. Excess solvent was removed under reduced pressure, and the remaining residue was treated with methanol, filtered and recrystallized from ethanol. Physicochemical and analytical data are recorded in Table 1 .
1 H-NMR and IR spectra are shown in Table 2 .
13 C-NMR spectra are recorded in Table 3 . To a solution of 2 (0.3g, 0.002 mol) in pyridine (10mL) was added the appropriate isocyanate or isothiocyanate (0.0042 mol), and the reaction mixture was heated under reflux for 5-8 h. After cooling to room temperature, the reaction mixture was poured on crushed ice and the separated solid product was filtered, washed thoroughly with water, dried and crystallized from acetic acid containing few drops of water. Physicochemical and analytical data are recorded in Table 1 .
1 H-NMR and IR spectra are shown in Table 2 . 13 C-NMR spectra are recorded in Table 3 .
3,6-Dimethyl-1-Substituted-Pyrano[4,3-C]Pyrazol-4(5H)-Ones (6)
A solution of dehydroacetic acid 1 (1.68 g, 0.01 mol) in ethanol (20 mL) was heated under reflux with the appropriate arylhydrazine (0.011 mol) for 3-4 h. The reaction mixture was concentrated to half its volume and allowed to cool. The solid product separated was filtered, washed with ethanol and recrystallized from ethanol. Physicochemical and analytical data are recorded in Table 1 . H-NMR and IR spectra are shown in Table 2 .
13 C-NMR spectra are recorded in Table 3 .
5-Amino-3,6-Dimethyl-1-Substituted-1H-Pyrazolo[4,3-C]Pyridin-4(1H)-Ones (7)
A solution of the appropriate 6 derivative (0.01 mol) in ethanol (20 mL) was refluxed with hydrazine hydrate (1.1 mL, 0.022 mol) for 2-4 h. The reaction mixture was concentrated to half its volume and allowed to cool. The solid product separated was filtered, washed with cold ethanol and recrystallized from ethanol. Physicochemical and analytical data are recorded in Table 1 . H-NMR and IR spectra are shown in Table 2 .
5-(Arylidenamino)-3,6-Dimethyl-1-Substituted-1H-Pyrazolo[4,3-C]Pyridin-4(5H)-Ones (8)
A mixture of the appropriate 7 derivative (0.001 mol) and the appropriate aldehyde (0.001 mol) in benzene (10 mL) was heated on a boiling water bath for 5-8 h. Excess solvent was removed under reduced pressure, and the remaining residue was treated with methanol, filtered and recrystallized from ethanol. Physicochemical and analytical data are recorded in Table 4 .
13 C-NMR spectra are recorded in Table 3 . To a solution of the appropriate 7 derivative (0.001 mol) in pyridine (10 mL) was added the appropriate benzenesulfonyl chloride derivative (0.0011 mol), and the mixture was heated under reflux for 3-4 h. After cooling to room temperature, the reaction mixture was poured on crushed ice and the separated solid product was filtered, washed thoroughly with water, dried and crystallized from a mixture of ethanol and benzene (3:1). Physicochemical and analytical data are recorded in Table 4 .
General Procedure for the Preparation of the N 1 -Substituted N 3 -(3,6-Dimethyl-4-Oxo-1-Substituted-1H-Pyrazolo[4,3-C]Pyridin-5(4H)-yl)ureas (10) and
To a solution of the appropriate 7 derivative (0.001 mol) in pyridine (10 mL) was added the appropriate isocyanate or isothiocyanate (0.0011 mol), and the reaction mixture was heated under reflux for 5-8 h. After cooling to room temperature, the reaction mixture was poured on crushed ice and the separated solid product was filtered, washed thoroughly with water, dried and crystallized from acetic acid containing few drops of water. Physicochemical and analytical data are recorded in Table 4 .
Results and Discussion
The starting compound in this research work is dehydroacetic acid; 3-acetyl-6-methyl-3H-pyran-2,4-dione 1; was purchased from ACROS Organics (Cat. No.11194). In scheme 1, when dehydroacetic acid 1 reacted with hydrazine hydrate, the 5-amino-3,6-dimethyl-1H-pyrazolo [4,3-c] pyridin-4(5H)-one 2 was obtained and utilized as the key intermediate in this part. Its IR spectrum showed an absorption band at1667 cm -1 due to the carbonyl group and a broad band at 3300-3370 cm -1 due to the (NH 2 & NH) absorptions. The 1 H-NMR spectrum (δ-ppm) of 2 showed the characteristic two singlets at 2.18, 2.51 corresponding to the methyl groups and a singlet at 6.56 due to C 7 -H. Its 13 C-NMR spectrum (δ-ppm) showed a characteristic singlet at 145.12 corresponding to the carbonyl group. Condensing 2 with the appropriate aldehyde gave rise to the corresponding 5-(arylideneamino)-3,6-dimethyl-1H-pyrazolo [4,3- On the other hand, reaction of dehydroacetic acid 1 with the appropriate substituted hydrazine derivative to obtain the 3,6-dimethyl-1-substitutedpyrano [4,3-c] pyrazol-4(5H)-ones 6. Their IR spectra showed absorption bands at 1720-1738 cm -1 due to the carbonyl groups. Reacting compounds 6 with hydrazine hydrate resulted in the formation of the key intermediates 5-amino-3,6-dimethyl-1-substituted-1H-pyrazolo [4,3-c] pyridin-4(5H)-ones 7. At this stage, condensing 7 with the appropriate aldehyde gave rise to the corresponding 5-(arylidenamino)-3,6-dimethyl-1-substituted-1H-pyrazolo[4,3-c]pyridin-4(5H)-ones 8. Their 1 H-NMR spectra (δ-ppm) are characterized by the presence of singlets at 8.05 to 8.18 due to the CH=N protons. Moreover, reacting 7 with benzenesulfonyl chloride or p-toluenesulfonyl chloride in the presence of pyridine led to the formation of the N-substituted benzenesulfonyl derivatives 9. Their IR spectra showed absorption bands at 1173-1185 and 1338-1345 cm -1 due to the SO 2 N groups. Their 1 H-NMR spectra (δ-ppm) revealed the new NH protons at 8.25-8.35, in addition to other signals assigned for the aromatic substituents. Finally, condensing 7 with different isocyanates and isothiocyanates in the presence of pyridine afforded the corresponding substituted ureido and thioureido derivatives 10 and 11, respectively. The IR spectra of these compounds revealed beside the characteristic absorption bands corresponding to the ester group, a characteristic C=S band at 1148-1155 cm -1 . Their 1 H-NMR spectra (δ-ppm) revealed the new NH protons at their expected ranges in addition to other signals assigned for the thioureido nitrogens and the respective substituents. Their 13 C-NMR spectra (δ-ppm) showed characteristic singlets at 181.5 to 185.12 corresponding to the C=S.
Biological Testings
After confirming the structure of the newly synthesized compounds using different spectral and analytical data, they were sent consequently to the Department of Health and Human Services, National Cancer Institute (NCI), Bethesda, Maryland, U.S.A to evaluate their in vitro antitumor activity. Out of the newly synthesized derivatives, 12 compounds namely; 3d,e, 4c, 5g, 6c, 7c, 8d,h, 9d, 10h and 11f,h; have been selected by the NCI to be evaluated for their preliminary antitumor activity. Unfortunately, most of them showed weak anticancer activity. In addition, the in vitro antibacterial and antifungal activities of the target compounds were also tested using the Agar-diffusion method. Test organisms utilized were Staphylococcus aureus as an example of Gram positive bacteria, Escherichia coli and as an example of Gram negative bacteria and Candida albicans as a representative of fungi. None of the tested compounds was able to exert significant antibacterial or antifungal activities. 
